Prognostic value of proliferating cell nuclear antigen in Wilms» tumour in children
- 1 February 2002
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 28 (1) , 67-71
- https://doi.org/10.1053/ejso.2001.1208
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- 16q heterozygosity loss in Wilms» tumour in children and its clinical importanceEuropean Journal of Surgical Oncology, 2000
- Histological analysis of aggressiveness and responsiveness in Wilms' tumorMedical and Pediatric Oncology, 1996
- Clinicopathologic correlates of loss of heterozygosity in Wilms' tumor: A preliminary analysisMedical and Pediatric Oncology, 1996
- The Treatment of Wilms Tumor: Results of the National Wilms Tumor StudiesHematology/Oncology Clinics of North America, 1995
- Expression of proliferating cell nuclear antigen in Wilms' tumors and other pediatric renal tumors: The correlation between histologic classification and proliferative activityJournal of Surgical Oncology, 1994
- Results of the Sixth International Society of Pediatric Oncology Wilms' Tumor Trial and Study: a risk-adapted therapeutic approach in Wilms' tumor.Journal of Clinical Oncology, 1993
- Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasmsActa Neuropathologica, 1993
- Epidemiology of Wilms tumorMedical and Pediatric Oncology, 1993
- PCNA and Ki67 expression in breast carcinoma: correlations with clinical and biological variables.Journal of Clinical Pathology, 1992
- Proliferating Cell Nuclear Antigen (PCNA) and Pediatric Tumors: Assessment of Proliferative ActivityPediatric Pathology, 1991